---
{"dg-publish":true,"permalink":"/USMLE/Renal/Rapidly progressive glomerulonephritis/"}
---

# Etiology

---
# Classifications
Three classifications, same as [[USMLE/Renal/Nephritic syndrome#Etiology\|Nephritic syndrome#Etiology]]
- **Type I ([[USMLE/Renal/Goodpasture syndrome\|Anti-GBM Disease]], ~10%):** Linear IgG & C3 deposits on IF.
	- Caused by autoantibodies against the α-3 chain of type IV [[USMLE/Biochemistry/Extracellular matrix\|collagen]] in the GBM.
	- **[[USMLE/Renal/Goodpasture syndrome\|Goodpasture Syndrome]]:** [[USMLE/Renal/Nephritic syndrome\|Glomerulonephritis]] + pulmonary hemorrhage (hemoptysis).
- **Type II (Immune-Complex Mediated, ~40%):** Granular IF deposits.
	- Caused by deposition of antigen-antibody complexes.
	- Associated with infections ([[USMLE/Renal/Poststreptococcal glomerulonephritis\|PSGN]]), autoimmune diseases ([[USMLE/Immunology/Systemic lupus erythematosus\|SLE]], [[USMLE/Renal/IgA nephropathy\|IgA nephropathy]]/[[USMLE/MSK/Vasculitides\|vasculitis]]), and cryoglobulinemia.
- **Type III (Pauci-Immune, ~50%):** No/minimal immune deposits on IF (hence "pauci").
	- Strongly associated with **[[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|Antineutrophil Cytoplasmic Antibodies]] ([[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|ANCA]])**.
	- **[[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|c-ANCA]] (anti-PR3):** [[USMLE/Blood/Granulomatosis with polyangiitis\|Granulomatosis with polyangiitis]] (Wegener's).
	- **[[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|p-ANCA]] (anti-MPO):** Microscopic polyangiitis, [[USMLE/Blood/Eosinophilic granulomatosis with polyangiitis\|Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss).

---
# Pathophysiology
- <span style="background:rgba(240, 200, 0, 0.2)">Severe glomerular injury leads to breaks in the glomerular basement membrane (GBM), allowing fibrin, inflammatory cells (macrophages), and parietal epithelial cells to proliferate in Bowman's space, forming a characteristic **crescent shape**.</span>![L13147.jpg](/img/user/appendix/L13147.jpg)
- Release of inflammatory cytokines → damage to the membrane of Bowman space and passage of cells from the interstitium into Bowman space
- This causes the formation of fibrin clots and proliferation of cells (e.g., macrophages, fibroblasts, neutrophils, epithelial cells) → crescent moon formation → compression of the glomerulus → renal dysfunction

---
# Clinical features


---
# Diagnostics
- **Serology:** Crucial for classification.
	- **Anti-GBM antibodies:** Type I.
	- **ANA, anti-dsDNA, low complement (C3/C4):** Type II (if SLE).
	- **c-ANCA (anti-PR3) / p-ANCA (anti-MPO):** Type III.

---
# Treatment
- **Urgent and aggressive immunosuppression** is required to prevent irreversible renal failure.
- **General approach:** High-dose corticosteroids (e.g., pulse methylprednisolone) PLUS another agent.
- **Specific therapy depends on type:**
	- **Type I (Anti-GBM):** Corticosteroids + Cyclophosphamide + <span style="background:rgba(240, 200, 0, 0.2)">**Plasmapheresis** (to remove circulating anti-GBM antibodies)</span>.
	- **Type II (Immune-Complex):** Treat the underlying disease (e.g., SLE with steroids + cyclophosphamide or mycophenolate).
	- **Type III (Pauci-Immune/ANCA):** Corticosteroids + Cyclophosphamide or **Rituximab**. Plasmapheresis may be used in severe cases (e.g., pulmonary hemorrhage, dialysis requirement).

>[!Mnemonic] 
><font color="#ffc000">三</font>心<font color="#ffc000">二</font>意<font color="#ffc000">激素</font>环（II型、III型）
><font color="#ffc000">好怕</font> (Goodpasture) <font color="#ffc000">血浆溢上</font>来（I型、III型）


---
